192 related articles for article (PubMed ID: 30852139)
1. Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized Mice.
Zhou J; Li H; Xia X; Herrera A; Pollock N; Reebye V; Sodergren MH; Dorman S; Littman BH; Doogan D; Huang KW; Habib R; Blakey D; Habib NA; Rossi JJ
Mol Ther; 2019 May; 27(5):999-1016. PubMed ID: 30852139
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer.
Hashimoto A; Sarker D; Reebye V; Jarvis S; Sodergren MH; Kossenkov A; Sanseviero E; Raulf N; Vasara J; Andrikakou P; Meyer T; Huang KW; Plummer R; Chee CE; Spalding D; Pai M; Khan S; Pinato DJ; Sharma R; Basu B; Palmer D; Ma YT; Evans J; Habib R; Martirosyan A; Elasri N; Reynaud A; Rossi JJ; Cobbold M; Habib NA; Gabrilovich DI
Clin Cancer Res; 2021 Nov; 27(21):5961-5978. PubMed ID: 34407972
[TBL] [Abstract][Full Text] [Related]
3. MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial.
Sarker D; Plummer R; Meyer T; Sodergren MH; Basu B; Chee CE; Huang KW; Palmer DH; Ma YT; Evans TRJ; Spalding DRC; Pai M; Sharma R; Pinato DJ; Spicer J; Hunter S; Kwatra V; Nicholls JP; Collin D; Nutbrown R; Glenny H; Fairbairn S; Reebye V; Voutila J; Dorman S; Andrikakou P; Lloyd P; Felstead S; Vasara J; Habib R; Wood C; Saetrom P; Huber HE; Blakey DC; Rossi JJ; Habib N
Clin Cancer Res; 2020 Aug; 26(15):3936-3946. PubMed ID: 32357963
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.
Guo H; Cooper S; Friedman AD
PLoS One; 2016; 11(3):e0150809. PubMed ID: 26937964
[TBL] [Abstract][Full Text] [Related]
5. Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma.
Setten RL; Lightfoot HL; Habib NA; Rossi JJ
Curr Pharm Biotechnol; 2018; 19(8):611-621. PubMed ID: 29886828
[TBL] [Abstract][Full Text] [Related]
6.
Glaser K; Silwedel C; Fehrholz M; Waaga-Gasser AM; Henrich B; Claus H; Speer CP
Front Cell Infect Microbiol; 2017; 7():484. PubMed ID: 29234642
[No Abstract] [Full Text] [Related]
7. Calprotectin expression in human monocytes: induction by porphyromonas gingivalis lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1beta.
Kido J; Hayashi N; Kataoka M; Nagata T
J Periodontol; 2005 Mar; 76(3):437-42. PubMed ID: 15857079
[TBL] [Abstract][Full Text] [Related]
8. Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14+ Monocytes.
Glaser K; Fehrholz M; Curstedt T; Kunzmann S; Speer CP
PLoS One; 2016; 11(1):e0146898. PubMed ID: 26790130
[TBL] [Abstract][Full Text] [Related]
9. Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer.
Reebye V; Huang KW; Lin V; Jarvis S; Cutilas P; Dorman S; Ciriello S; Andrikakou P; Voutila J; Saetrom P; Mintz PJ; Reccia I; Rossi JJ; Huber H; Habib R; Kostomitsopoulos N; Blakey DC; Habib NA
Oncogene; 2018 Jun; 37(24):3216-3228. PubMed ID: 29511346
[TBL] [Abstract][Full Text] [Related]
10. The new generation synthetic reconstituted surfactant CHF5633 suppresses LPS-induced cytokine responses in human neonatal monocytes.
Glaser K; Fehrholz M; Papsdorf M; Curstedt T; Kunzmann S; Speer CP
Cytokine; 2016 Oct; 86():119-123. PubMed ID: 27505451
[TBL] [Abstract][Full Text] [Related]
11. Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer.
Voutila J; Reebye V; Roberts TC; Protopapa P; Andrikakou P; Blakey DC; Habib R; Huber H; Saetrom P; Rossi JJ; Habib NA
Mol Ther; 2017 Dec; 25(12):2705-2714. PubMed ID: 28882451
[TBL] [Abstract][Full Text] [Related]
12. MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models.
Huang KW; Tan CP; Reebye V; Chee CE; Zacharoulis D; Habib R; Blakey DC; Rossi JJ; Habib N; Sodergren MH
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502076
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes.
Donnelly RP; Freeman SL; Hayes MP
J Immunol; 1995 Aug; 155(3):1420-7. PubMed ID: 7636207
[TBL] [Abstract][Full Text] [Related]
14. Effects of the second-generation synthetic lipid A analogue E5564 on responses to endotoxin in [corrected] equine whole blood and monocytes.
Figueiredo MD; Moore JN; Vandenplas ML; Sun WC; Murray TF
Am J Vet Res; 2008 Jun; 69(6):796-803. PubMed ID: 18518661
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of the new generation synthetic surfactant CHF5633 on Ureaplasma-induced cytokine responses in human monocytes.
Glaser K; Fehrholz M; Henrich B; Claus H; Papsdorf M; Speer CP
Expert Rev Anti Infect Ther; 2017 Feb; 15(2):181-189. PubMed ID: 27828734
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Tumor Necrosis Factor-α and Interleukin-1β Production in Lipopolysaccharide-Stimulated Monocytes by Methanolic Extract of Elephantopus scaber Linn and Identification of Bioactive Components.
Abhimannue AP; Mohan MC; B PK
Appl Biochem Biotechnol; 2016 Jun; 179(3):427-43. PubMed ID: 26875087
[TBL] [Abstract][Full Text] [Related]
17. A heteroglycan from the cyanobacterium Nostoc commune modulates LPS-induced inflammatory cytokine secretion by THP-1 monocytes through phosphorylation of ERK1/2 and Akt.
Olafsdottir A; Thorlacius GE; Omarsdottir S; Olafsdottir ES; Vikingsson A; Freysdottir J; Hardardottir I
Phytomedicine; 2014 Sep; 21(11):1451-7. PubMed ID: 24877713
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase C-δ(1) regulates interleukin-1β and tumor necrosis factor-α mRNA expression.
Chung E; Jakinovich P; Bae A; Rebecchi M
Exp Cell Res; 2012 Oct; 318(16):1987-93. PubMed ID: 22710061
[TBL] [Abstract][Full Text] [Related]
19. Opposite effects of interferon-gamma and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities.
Aloisi F; De Simone R; Columba-Cabezas S; Levi G
J Neurosci Res; 1999 Jun; 56(6):571-80. PubMed ID: 10374812
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha.
Barsig J; Küsters S; Vogt K; Volk HD; Tiegs G; Wendel A
Eur J Immunol; 1995 Oct; 25(10):2888-93. PubMed ID: 7589088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
